rs201342438

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001194998.2(CEP152):​c.2878T>C​(p.Trp960Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00365 in 1,591,736 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0025 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 13 hom. )

Consequence

CEP152
NM_001194998.2 missense

Scores

7
7
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:6B:4

Conservation

PhyloP100: 6.71

Publications

14 publications found
Variant links:
Genes affected
CEP152 (HGNC:29298): (centrosomal protein 152) This gene encodes a protein that is thought to be involved with centrosome function. Mutations in this gene have been associated with primary microcephaly (MCPH4). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]
CEP152 Gene-Disease associations (from GenCC):
  • microcephaly with or without short stature
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Seckel syndrome 5
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • microcephaly 9, primary, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Seckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.048254102).
BP6
Variant 15-48756370-A-G is Benign according to our data. Variant chr15-48756370-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 95651.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00254 (386/152096) while in subpopulation NFE AF = 0.004 (272/67994). AF 95% confidence interval is 0.00361. There are 1 homozygotes in GnomAd4. There are 172 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 13 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP152NM_001194998.2 linkc.2878T>C p.Trp960Arg missense_variant Exon 20 of 27 ENST00000380950.7 NP_001181927.1 O94986-4Q3B7A2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP152ENST00000380950.7 linkc.2878T>C p.Trp960Arg missense_variant Exon 20 of 27 1 NM_001194998.2 ENSP00000370337.2 O94986-4
CEP152ENST00000399334.7 linkc.2878T>C p.Trp960Arg missense_variant Exon 20 of 26 1 ENSP00000382271.3 O94986-3
CEP152ENST00000325747.9 linkc.2599T>C p.Trp867Arg missense_variant Exon 19 of 25 1 ENSP00000321000.5 O94986-1

Frequencies

GnomAD3 genomes
AF:
0.00255
AC:
387
AN:
151978
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000605
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00354
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.000756
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00401
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00253
AC:
591
AN:
233654
AF XY:
0.00251
show subpopulations
Gnomad AFR exome
AF:
0.000394
Gnomad AMR exome
AF:
0.00264
Gnomad ASJ exome
AF:
0.00628
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000867
Gnomad NFE exome
AF:
0.00369
Gnomad OTH exome
AF:
0.00236
GnomAD4 exome
AF:
0.00377
AC:
5427
AN:
1439640
Hom.:
13
Cov.:
32
AF XY:
0.00368
AC XY:
2629
AN XY:
713762
show subpopulations
African (AFR)
AF:
0.000652
AC:
21
AN:
32230
American (AMR)
AF:
0.00276
AC:
113
AN:
40972
Ashkenazi Jewish (ASJ)
AF:
0.00594
AC:
149
AN:
25100
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39452
South Asian (SAS)
AF:
0.00117
AC:
95
AN:
81332
European-Finnish (FIN)
AF:
0.000910
AC:
48
AN:
52768
Middle Eastern (MID)
AF:
0.000356
AC:
2
AN:
5622
European-Non Finnish (NFE)
AF:
0.00433
AC:
4776
AN:
1102840
Other (OTH)
AF:
0.00376
AC:
223
AN:
59324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
361
722
1083
1444
1805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00254
AC:
386
AN:
152096
Hom.:
1
Cov.:
32
AF XY:
0.00231
AC XY:
172
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.000603
AC:
25
AN:
41470
American (AMR)
AF:
0.00353
AC:
54
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4818
European-Finnish (FIN)
AF:
0.000756
AC:
8
AN:
10582
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00400
AC:
272
AN:
67994
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00361
Hom.:
1
Bravo
AF:
0.00271
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.00109
AC:
4
ESP6500EA
AF:
0.00427
AC:
35
ExAC
AF:
0.00243
AC:
294
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:6Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:2
Aug 08, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant previously reported in the heterozygous state in three unrelated individuals with atrioventricular septal defects; however, these individuals did not have features of CEP152-related disorders and did not have a second variant identified in CEP152 (PMID: 25996639); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25996639, 31696992, 34402213) -

Mar 13, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CEP152: BS2 -

Microcephaly 9, primary, autosomal recessive Pathogenic:1Uncertain:2
-
Institut de Recherche Interdisciplinaire en Biologie Humaine et Moleculaire, Universite Libre de Bruxelles
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Feb 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Seckel syndrome 5;C3553886:Microcephaly 9, primary, autosomal recessive Uncertain:1
May 23, 2017
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CEP152-related disorder Benign:1
Mar 19, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Seckel syndrome 5 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
-0.030
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.24
T;.;.
Eigen
Pathogenic
0.76
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.74
T;T;T
M_CAP
Uncertain
0.090
D
MetaRNN
Benign
0.048
T;T;T
MetaSVM
Uncertain
-0.17
T
MutationAssessor
Uncertain
2.6
M;M;.
PhyloP100
6.7
PrimateAI
Uncertain
0.67
T
PROVEAN
Pathogenic
-8.6
D;D;D
REVEL
Uncertain
0.41
Sift
Pathogenic
0.0
D;D;D
Sift4G
Pathogenic
0.0010
D;D;D
Polyphen
1.0
D;.;D
Vest4
0.87
MutPred
0.44
Gain of solvent accessibility (P = 0.0171);Gain of solvent accessibility (P = 0.0171);.;
MVP
0.92
MPC
0.51
ClinPred
0.074
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.94
gMVP
0.61
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201342438; hg19: chr15-49048567; COSMIC: COSV57860954; API